Lung Diseases, Interstitial Companies - LARVOL Sigma

Lung Diseases, Interstitial

Welcome, Profile Billing Logout

65 Mechanisms of Action


Phase N/A 1 2 3 4 Products		0	5										10										15										20										25										30										35										40										45										50



Generic mfg.



J&J



Roche



Sanofi



Bayer



Biogen



GSK



Pfizer



AbbVie



Amgen



Eli Lilly



Merck (MSD)



Novartis



Almirall



Amarillo



Anthera Pharma



AstraZeneca



BMS



Celularity



Chiesi



Clinigen



Curis



FibroGen



Gilead



Hayashibara



Horizon Therapeutics



ImmuneWorks



LEO Pharma



Mitsubishi Tanabe



MorphoSys



Mundipharma



National Cancer Institute



NeoPharm



Nippon Shinyaku



Ono Pharma



Otsuka



Simcere



University of Copenhagen



Viatris



Zenyaku Holdings



Zydus Lifesci